16 September 2026 editorial review · Trial
Low-dose glucagon before exercise while using AID: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the trial evidence page →Primary-agent trial review — 16 September 2026
Assessment: Registry intervention is glucagon, not ZT01; removed unrelated Zucara product link.
Registry: NCT07427251; RECRUITING; updated 2026-08-13; enrollment 18 (ESTIMATED); results not posted.
Endpoint comparison: Change in plasma glucose (PG) from exercise initiation to the nadir during exercise and throughout the 2-hour post-exercise period between visit GCN and CHO (From exercise initiation until two hours following exercise).
Sources for this record: NCT07427251: Low-dose glucagon before exercise while using AID (registry).
Limits: Source access and review depth vary. Registry fields establish the registered study, not clinical benefit, product approval or current local access. Cited-source reachability alone was not treated as verification of its claims.